Skip to content

Author

N. Xhabija

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Association of tirzepatide with reverse cardiac remodeling and improved diastolic function in obesity-related HFpEF: A prospective real-world cohort study.

BACKGROUND Obesity-related heart failure with preserved ejection fraction (HFpEF) is characterized by concentric remodeling, diastolic dysfunction, and systemic inflammation. Tirzepatide, a dual GIP/GLP-1 receptor agonist, produces substantial weight loss, but real-world echocardiographic evidence of cardiac reverse re...

J. Karanxha, Mirjeta Guni, N. Xhabija et al. · 0 citations
Open access Aug 2026

EP854 - ECE_3854 - Off-label use of semaglutide (Ozempic®) for weight reduction: a real-world case series of 20 patients

Obesity is a chronic metabolic condition closely linked to insulin resistance and increased cardiometabolic risk. While semaglutide 2.4 mg is specifically approved for obesity treatment, lower doses of semaglutide (Ozempic®) are frequently used off-label for weight reduction in everyday clinical practice. However...

E. Puca, S. Bitri, N. Xhabija et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.